MAPK3 and cancer: In addition, the observation that CLIC1 overexpression can activate ERK1/2 and NF-κB p65 raises the possibility that MCPyV ST targets CLIC1/CLIC4 to regulate the mitogenic signaling pathways that contribute to cancer metastasis (20, 21).